RenovoRx highlighted the recent leadership promotions of Leesa Gentry to chief clinical officer and Ronald Kocak, CPA to principal accounting officer. Shaun Bagai, CEO of RenovoRx, commented, “We are delighted to promote Leesa and Ron to their new leadership roles, which reflects our commitment to assembling a dynamic team poised to continue to lead a successful clinical pathway for our proprietary therapy platform. We have streamlined our team, focusing our efforts on strategic initiatives to drive growth and innovation. On behalf of our Board of Directors, I extend our gratitude to Leesa and Ron on their hard work and dedication to date and congratulate them on their well-deserved promotions.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on RNXT:
- RenovoRx Struggles to Avoid Nasdaq Delisting Amid Leadership Changes
- RenovoRx sees 2nd interim analysis on Phase III TIGeR-PaC by 2024-end
- Macy’s upgraded, New York Community downgraded: Wall Street’s top analyst calls
- RenovoRx initiated with a Buy at Alliance Global Partners
- RenovoRx Announces Completion of Recent Offering